Bio-Rad Reports First-Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. IVBIY
9. SPY
10. FIX

Go back to Bio-Rad Reports First-Quarter 2024 Financial Results

This stock offers one of the most favorable long-term risk/rewards in biotech: RBC

May 8, 2024 4:30 PM EDT

RBC Capital analysts highlighted one stock they believe has a favorable risk/reward in a note Wednesday.

The bank continues to view Bio-Rad Labs (NYSE: BIO) as one of the most compelling long-term investment opportunities in its coverage universe, emphasizing a favorable risk/reward profile.

Despite a 25%... More

Bio-Rad Labs (BIO) PT Lowered to $414 at RBC Capital

May 8, 2024 6:22 AM EDT

RBC Capital analyst Conor McNamara lowered the price target on Bio-Rad Labs (NYSE: BIO) to $414.00 (from $420.00) while maintaining a Outperform rating.

The analyst comments "We continue to view BIO as one of the most favorable long-term risk/reward names under coverage; though... More